The impact of antibiotics on clinical response over time in uncomplicated cellulitis: a systematic review and meta-analysis

[1] Raff AB(2016)Cellulitis: a review JAMA 316 325-337

[2] Kroshinsky D(2008)Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus Ann Emerg Med 51 291-298

[3] Pallin DJ(2009)Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department CJEM 11 430-438

[4] Egan DJ(2010)Interventions for cellulitis and erysipelas Cochrane Database Syst Rev 70 581-586

[5] Pelletier AJ(2015)Oral versus parenteral antimicrobials for the treatment of cellulitis: a randomized non-inferiority trial J Antimicrob Chemother 325 864-52

[6] Stenstrom R(2002)Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial BMJ 59 e10-180

[7] Grafstein E(2014)Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America Clin Infect Dis 19 175-1122

[8] Romney M(2017)Antimicrobial treatment decision for non-purulent skin and soft tissue infections in the emergency department CJEM 31 1119-83

[9] Kilburn SA(2019)Picking the low-hanging fruit: why not choose oral antibiotics for skin and soft-tissue infections in the emergency department Emerg Med Australas 48 75-2096

[10] Featherstone P(2020)Treatment failure definitions for non-purulent skin and soft tissue infections: a systematic review Infection 317 2088-531

[1] Raff AB(2016)Cellulitis: a review JAMA 316 325-337

[2] Kroshinsky D(2008)Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus Ann Emerg Med 51 291-298

[3] Pallin DJ(2009)Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department CJEM 11 430-438

[4] Egan DJ(2010)Interventions for cellulitis and erysipelas Cochrane Database Syst Rev 70 581-586

[5] Pelletier AJ(2015)Oral versus parenteral antimicrobials for the treatment of cellulitis: a randomized non-inferiority trial J Antimicrob Chemother 325 864-52

[6] Stenstrom R(2002)Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial BMJ 59 e10-180

[7] Grafstein E(2014)Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America Clin Infect Dis 19 175-1122

[8] Romney M(2017)Antimicrobial treatment decision for non-purulent skin and soft tissue infections in the emergency department CJEM 31 1119-83

[9] Kilburn SA(2019)Picking the low-hanging fruit: why not choose oral antibiotics for skin and soft-tissue infections in the emergency department Emerg Med Australas 48 75-2096

[10] Featherstone P(2020)Treatment failure definitions for non-purulent skin and soft tissue infections: a systematic review Infection 317 2088-531